UMediC Group Berhad Income Statement

Financials in millions MYR. Fiscal year is August - July.

Millions MYR. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Revenue	49.67	48.56	54.57	45.43	50.74	34.12
Revenue Growth (YoY)	-6.46%	-11.00%	20.11%	-10.46%	48.72%	44.09%
Cost of Revenue	27	26.2	31.9	26.5	32.08	21.55
Gross Profit	22.68	22.36	22.67	18.93	18.66	12.56
Selling, General & Admin	13.07	12.69	11.43	7.64	10.03	5.88
Operating Expenses	13.27	12.9	11.46	7.63	10.01	5.89
Operating Income	9.4	9.47	11.22	11.3	8.65	6.68
Interest Expense	-0.07	-0.07	-0.14	-0.25	-0.81	-0.73
Interest & Investment Income	-	-	-	-	0.12	0.04
Other Non Operating Income (Expenses)	1.38	1.45	1.56	1.88	0.53	0.55
EBT Excluding Unusual Items	10.71	10.85	12.64	12.93	8.48	6.54
Other Unusual Items	-	-	-	-	-	0.01
Pretax Income	10.71	10.85	12.64	12.93	8.48	6.55
Income Tax Expense	2.42	2.59	3.34	2.57	2.06	1.47
Earnings From Continuing Operations	8.29	8.26	9.3	10.36	6.43	5.09
Minority Interest in Earnings	-0.22	-0.13	-0.31	-0.05	-	-
Net Income	8.07	8.13	8.99	10.32	6.43	5.09
Net Income to Common	8.07	8.13	8.99	10.32	6.43	5.09
Net Income Growth	-9.83%	-9.53%	-12.84%	60.52%	26.33%	110.32%
Shares Outstanding (Basic)	374	374	374	374	234	374
Shares Outstanding (Diluted)	374	374	374	374	234	374
Shares Change (YoY)	-	-	-	59.51%	-37.31%	-
EPS (Basic)	0.02	0.02	0.02	0.03	0.03	0.01
EPS (Diluted)	0.02	0.02	0.02	0.03	0.03	0.01
EPS Growth	-9.52%	-9.54%	-12.84%	0.64%	101.51%	110.33%
Free Cash Flow	-2.62	3.14	-2.18	-3.51	7.47	-5.7
Free Cash Flow Per Share	-0.01	0.01	-0.01	-0.01	0.03	-0.01
Gross Margin	45.65%	46.05%	41.55%	41.67%	36.78%	36.82%
Operating Margin	18.93%	19.49%	20.55%	24.88%	17.04%	19.57%
Profit Margin	16.24%	16.75%	16.48%	22.71%	12.67%	14.91%
Free Cash Flow Margin	-5.28%	6.47%	-4.00%	-7.72%	14.72%	-16.71%
EBITDA	12.45	12.31	13.58	13.35	10.18	7.2
EBITDA Margin	25.07%	25.35%	24.89%	29.38%	20.06%	21.12%
D&A For EBITDA	3.05	2.84	2.37	2.05	1.53	0.53
EBIT	9.4	9.47	11.22	11.3	8.65	6.68
EBIT Margin	18.93%	19.49%	20.55%	24.88%	17.04%	19.57%
Effective Tax Rate	22.58%	23.84%	26.45%	19.86%	24.24%	22.38%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.